Related Experiment Video
Updated: May 12, 2026
Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets
Published on: May 11, 2015
Nuclear GAPDH: changing the fate of Müller cells in diabetes
Prathiba Jayaguru1, Susanne Mohr
1Department of Physiology, Michigan State University, 3175 Biomedical Physical Sciences, East Lansing, MI 48824 USA.
Abstract:
Müller cells, the primary glial cells are a crucial component of the retinal tissue performing a wide range of functions including maintaining the blood-retinal barrier. Several studies suggest that diabetes leads to Müller cell dysfunction and loss. The pathophysiology of hyperglycemia-induced cellular injury of Müller cells remains only poorly understood. Recently, the concept that translocation of the predominantly cytosolic glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to the nucleus and its accumulation in this cellular compartment alters transcriptional events associated with cell death induction has gained major interest. High glucose conditions induce nuclear translocation and accumulation of GAPDH in the nucleus of Müller cells in vivo and in vitro. With regards to Müller cell dysfunction, the effects of nuclear accumulation of GAPDH are multifaceted. Considering the functional versatility of GAPDH including gene regulation, DNA repair, telomere protection, etc., it is of immense importance to explore possible GAPDH actions to unravel the mysteries around the role of GAPDH in hyperglycemia-induced cellular changes in order to develop novel therapeutic strategies. Therefore, this review focuses on the molecular events associated with the nuclear translocation of GAPDH and how it affects the fate of Müller cells in diabetes.
Insights
Diabetes causes Müller cell dysfunction by altering the nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Understanding this process is key to developing new diabetes therapies.
Area of Science:
- Retinal Biology
- Glial Cell Function
- Diabetic Complications
Background:
- Müller cells are vital retinal glial cells maintaining the blood-retinal barrier.
- Diabetes is known to cause Müller cell dysfunction and loss.
- The precise mechanisms of hyperglycemia-induced Müller cell injury are not fully understood.
Purpose of the Study:
- To investigate the role of nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in Müller cell dysfunction under high glucose conditions.
- To explore the molecular events linking GAPDH nuclear accumulation to Müller cell fate in diabetes.
- To identify potential therapeutic targets for diabetic retinal complications.
Main Methods:
- Review of existing literature on Müller cells, diabetes, and GAPDH.
- Analysis of studies demonstrating high glucose-induced nuclear translocation of GAPDH in Müller cells (in vivo and in vitro).
- Discussion of the multifaceted effects of nuclear GAPDH accumulation on cellular functions.
Main Results:
- High glucose conditions promote the nuclear translocation and accumulation of GAPDH in Müller cells.
- Nuclear GAPDH influences transcriptional events potentially leading to cell death.
- GAPDH has diverse functions including gene regulation and DNA repair, suggesting complex roles in cellular response.
Conclusions:
- Nuclear accumulation of GAPDH is a significant factor in hyperglycemia-induced Müller cell dysfunction.
- Further research into GAPDH's nuclear actions is crucial for understanding diabetic retinal pathology.
- Targeting GAPDH nuclear translocation may offer novel therapeutic strategies for diabetic eye diseases.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
01:20Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...